Start by defining the dystonia phenotype
A movement-disorder assessment should document which body regions are involved, whether symptoms are focal, segmental or generalized, whether they are task-specific or continuous and whether tremor, pain or other neurological signs are present. Cervical dystonia, blepharospasm, writer's cramp and generalized dystonia can require very different treatment pathways.
- Body regions affected and pattern of abnormal posture or movement
- Age at symptom onset and progression over time
- Task-specific triggers and sensory tricks when present
- Associated tremor, pain, gait or speech/swallowing symptoms
- Family history and any previous genetic evaluation
- Exposure to dopamine-blocking or other potentially relevant medicines
Secondary causes may change the treatment plan
Not every dystonia is primary or isolated. The specialist review may consider structural brain disease, medication-related syndromes, metabolic or genetic disorders and other neurological conditions when the history or examination suggests them. Imaging, laboratory testing or genetic assessment is therefore case-specific rather than routine for every patient.
Botulinum toxin is central for many focal dystonias
For focal or segmental dystonia affecting selected muscle groups, botulinum-toxin injections can reduce excessive muscle activity. The treatment is not a one-time cure: the effect is temporary, injection patterns often need refinement over repeated sessions, and experienced muscle selection is important for balancing benefit with weakness or other adverse effects.
Medication and rehabilitation remain part of the pathway
Oral medication may be useful in selected patients, especially in broader or generalized dystonia, although response and tolerability vary. Physiotherapy, occupational therapy, speech or swallowing therapy and pain management can also be relevant depending on the body regions involved and the functional impact of symptoms.
DBS is reserved for selected severe treatment-refractory dystonia
Charité and Freiburg include dystonia among the movement disorders treated with deep brain stimulation. DBS is generally considered after the diagnosis has been confirmed and appropriate non-surgical treatment has not provided adequate functional control. The likely benefit depends on dystonia subtype, cause, duration, fixed musculoskeletal changes and other clinical factors, so candidacy cannot be determined from the diagnosis name alone.
DBS requires long-term programming, not only surgery
DBS involves implanted electrodes and a pulse generator, followed by repeated programming to find settings that balance symptom improvement and side effects. Dystonia can improve gradually rather than immediately, so international patients should plan who will provide programming, device checks and long-term follow-up after returning home.
Previous treatment records are especially important
A second-opinion team needs to know which muscles were injected, the botulinum-toxin product and dose when available, which oral medicines were tried and whether previous surgery or DBS has already been performed. Without this history it is difficult to judge whether treatment has truly failed or simply has not yet been optimized.
Acute severe deterioration is not a routine travel scenario
Rapidly worsening generalized spasms, breathing difficulty, severe swallowing problems, fever, dehydration or other acute deterioration can require urgent local medical assessment. Planned medical travel is appropriate for stable specialist review, treatment optimization or elective advanced-therapy evaluation, not for an unstable emergency.
What to send for a German dystonia second opinion
A concise record package should show both the movement pattern and the treatment history.
- Neurology or movement-disorder reports
- Short videos showing the abnormal posture or movement during typical tasks
- Current medication list and previous dystonia medication trials
- Botulinum-toxin records including muscles and doses when available
- Brain MRI or other investigations already performed
- Genetic or metabolic test results if previously obtained
- Physiotherapy, occupational-therapy or speech/swallowing assessments when relevant
- Previous DBS or other surgery reports and device details
- A specific question: confirm diagnosis, optimize injections/medication, or assess DBS candidacy
Official sources
Sources last checked 2026-09-01. Clinical pathways, eligibility and hospital procedures can change; confirm current requirements directly with the treating center.
- Movement Disorders – dystonia and advanced therapy pathway — Charité – Universitätsmedizin Berlin ↗
- Functional Neurosurgery / Deep Brain Stimulation — Charité – Universitätsmedizin Berlin ↗
- Stereotactic and Functional Neurosurgery — University Medical Center Freiburg ↗
- Deep brain stimulation – movement disorders — University Medical Center Freiburg ↗